Using QPOP to Predict Treatment for Sarcomas and Melanomas
N/A
This is a multi-cohort proof of concept study involving patients with sarco...
Status
Recruiting
Location
National Cancer Centre Singapore
Start Date
2020-09-08
Trial ID
NCT04986748
Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer
PHASE1
Based on proof-of-concept study, the investigators hypothesise that the QPO...